teclistamab-cqyv 153 MG per 1.7 ML Injection
- RxCUI
- 2619441
- RxNorm name
- teclistamab-cqyv 153 MG per 1.7 ML Injection
- Display name
- teclistamab-cqyv 153 MG per 1.7 ML Injection
- Full name
- teclistamab-cqyv 153 MG per 1.7 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:59
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761291 | Tecvayli | teclistamab-cqyv | 351(a) | Rx | 2026-10-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 54e0f974-ccee-44ea-9254-40e9883cee1e | teclistamab-cqyv 153 MG in 1.7 ML Injection [PSN] · 1.7 ML teclistamab-cqyv 90 MG/ML Injection [SCD] · teclistamab-cqyv 153 MG per 1.7 ML Injection [SY] | 3 | 16 | These highlights do not include all the information needed to use TECVAYLI safely and effectively. See full prescribing information for TECVAYLI. TECVAYLI ® (teclistamab-cqyv) injection, for subcutaneous use Initial U.S. Approval: 2022 | 20260310 |